331 related articles for article (PubMed ID: 9428011)
1. The results of vitreous surgery for chronic macular holes.
Thompson JT; Sjaarda RN; Lansing MB
Retina; 1997; 17(6):493-501. PubMed ID: 9428011
[TBL] [Abstract][Full Text] [Related]
2. Vitrectomy, fluid-gas exchange and transforming growth factor--beta-2 for the treatment of traumatic macular holes.
Rubin JS; Glaser BM; Thompson JT; Sjaarda RN; Pappas SS; Murphy RP
Ophthalmology; 1995 Dec; 102(12):1840-5. PubMed ID: 9098285
[TBL] [Abstract][Full Text] [Related]
3. Anatomical outcomes of surgery for idiopathic macular hole as determined by optical coherence tomography.
Ip MS; Baker BJ; Duker JS; Reichel E; Baumal CR; Gangnon R; Puliafito CA
Arch Ophthalmol; 2002 Jan; 120(1):29-35. PubMed ID: 11786054
[TBL] [Abstract][Full Text] [Related]
4. The role of vitreoretinal surgery in the treatment of posttraumatic macular hole.
García-Arumí J; Corcostegui B; Cavero L; Sararols L
Retina; 1997; 17(5):372-7. PubMed ID: 9355183
[TBL] [Abstract][Full Text] [Related]
5. Surgical treatment of macular holes with multiple recurrences.
Thompson JT; Sjaarda RN
Ophthalmology; 2000 Jun; 107(6):1073-7. PubMed ID: 10857825
[TBL] [Abstract][Full Text] [Related]
6. Comparison of recombinant transforming growth factor-beta-2 and placebo as an adjunctive agent for macular hole surgery.
Thompson JT; Smiddy WE; Williams GA; Sjaarda RN; Flynn HW; Margherio RR; Abrams GW
Ophthalmology; 1998 Apr; 105(4):700-6. PubMed ID: 9544645
[TBL] [Abstract][Full Text] [Related]
7. Vitrectomy for the treatment of full-thickness stage 3 or 4 macular holes. Results of a multicentered randomized clinical trial. The Vitrectomy for Treatment of Macular Hole Study Group.
Freeman WR; Azen SP; Kim JW; el-Haig W; Mishell DR; Bailey I
Arch Ophthalmol; 1997 Jan; 115(1):11-21. PubMed ID: 9006420
[TBL] [Abstract][Full Text] [Related]
8. Prospective randomized trial of vitrectomy or observation for stage 2 macular holes. Vitrectomy for Macular Hole Study Group.
Kim JW; Freeman WR; Azen SP; el-Haig W; Klein DJ; Bailey IL
Am J Ophthalmol; 1996 Jun; 121(6):605-14. PubMed ID: 8644802
[TBL] [Abstract][Full Text] [Related]
9. Vitreous surgery for chronic macular holes.
Roth DB; Smiddy WE; Feuer W
Ophthalmology; 1997 Dec; 104(12):2047-52. PubMed ID: 9400764
[TBL] [Abstract][Full Text] [Related]
10. CLOSING MACULAR HOLES WITH "MACULAR PLUG" WITHOUT GAS TAMPONADE AND POSTOPERATIVE POSTURING.
Chakrabarti M; Benjamin P; Chakrabarti K; Chakrabarti A
Retina; 2017 Mar; 37(3):451-459. PubMed ID: 27491044
[TBL] [Abstract][Full Text] [Related]
11. Macular hole surgery in high myopia.
Patel SC; Loo RH; Thompson JT; Sjaarda RN
Ophthalmology; 2001 Feb; 108(2):377-80. PubMed ID: 11158817
[TBL] [Abstract][Full Text] [Related]
12. Vitrectomy for chronic macular holes.
Stec LA; Ross RD; Williams GA; Trese MT; Margherio RR; Cox MS
Retina; 2004 Jun; 24(3):341-7. PubMed ID: 15187653
[TBL] [Abstract][Full Text] [Related]
13. Long-term anatomic and visual acuity outcomes after initial anatomic success with macular hole surgery.
Scott IU; Moraczewski AL; Smiddy WE; Flynn HW; Feuer WJ
Am J Ophthalmol; 2003 May; 135(5):633-40. PubMed ID: 12719070
[TBL] [Abstract][Full Text] [Related]
14. Progression of nuclear sclerosis and long-term visual results of vitrectomy with transforming growth factor beta-2 for macular holes.
Thompson JT; Glaser BM; Sjaarda RN; Murphy RP
Am J Ophthalmol; 1995 Jan; 119(1):48-54. PubMed ID: 7825689
[TBL] [Abstract][Full Text] [Related]
15. Revisiting autologous platelets as an adjuvant in macular hole repair: chronic macular holes without prone positioning.
Kapoor KG; Khan AN; Tieu BC; Khurshid GS
Ophthalmic Surg Lasers Imaging; 2012 Jul; 43(4):291-5. PubMed ID: 22589336
[TBL] [Abstract][Full Text] [Related]
16. SULFURHEXAFLUORIDE (SF6) VERSUS PERFLUOROPROPANE (C3F8) GAS AS TAMPONADE IN MACULAR HOLE SURGERY.
Modi A; Giridhar A; Gopalakrishnan M
Retina; 2017 Feb; 37(2):283-290. PubMed ID: 28118283
[TBL] [Abstract][Full Text] [Related]
17. Effects of intraocular bubble duration in the treatment of macular holes by vitrectomy and transforming growth factor-beta 2.
Thompson JT; Glaser BM; Sjaarda RN; Murphy RP; Hanham A
Ophthalmology; 1994 Jul; 101(7):1195-200. PubMed ID: 8035983
[TBL] [Abstract][Full Text] [Related]
18. [Visual development of postoperative persistent macular holes with and without surgical revision].
Schüler A; Lucke K; Bopp S
Klin Monbl Augenheilkd; 2009 Nov; 226(11):927-32. PubMed ID: 19798626
[TBL] [Abstract][Full Text] [Related]
19. Idiopathic macular hole surgery with low-concentration infracyanine green-assisted peeling of the internal limiting membrane.
Lanzetta P; Polito A; Del Borrello M; Narayanan R; Shah VA; Frattolillo A; Bandello F
Am J Ophthalmol; 2006 Nov; 142(5):771-6. PubMed ID: 17056361
[TBL] [Abstract][Full Text] [Related]
20. Vitrectomy without face-down posturing for idiopathic macular holes.
Nadal J; Delas B; Piñero A
Retina; 2012 May; 32(5):918-21. PubMed ID: 22080914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
